1. |
Low-dose OCs approved in Japanongoing issues |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 2-2
&NA;,
Preview
|
PDF (769KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
2. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 3-3
&NA;,
Preview
|
PDF (746KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
3. |
Interferon-&bgr;-1b for MSmodest benefits at high cost |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 4-4
&NA;,
Preview
|
PDF (721KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
4. |
Abciximab in coronary stentingimproved survival at acceptable cost |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 5-5
&NA;,
Preview
|
PDF (786KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
5. |
Mesalazine induces apoptosis in colorectal cancer cells |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 6-6
&NA;,
Preview
|
PDF (696KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
6. |
Botulinum toxin B effective in cervical dystonia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 7-7
&NA;,
Preview
|
PDF (698KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
7. |
News from the 72nd Scientific Sessions of the American Heart AssociationAtlanta, US November 1999 |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 8-9
&NA;,
Preview
|
PDF (1529KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
8. |
Mortality reduction with &bgr;-blockers in diabetes |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 10-10
&NA;,
Preview
|
PDF (760KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
9. |
Insulin back into action with rosiglitazone |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 11-12
Carmen Innes,
Preview
|
PDF (1528KB)
|
|
摘要:
Rosiglitazone is an oral antihyperglycaemic agent that works by reducing insulin resistance - a problem that occurs when cells respond poorly to insulin, causing plasma glucose levels to rise. Studies presented at the 35th Annual Meeting of the European Association for the Study of Diabetes [Brussels, Belgium; September-October 1999] suggest that by reducing insulin resistance, rosiglitazone may provide long-term control of plasma glucose levels in patients with type 2 diabetes mellitus.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1218,
1999,
Page 12-12
&NA;,
Preview
|
PDF (784KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|